Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess whether vaccination with monovalent A/California/7/2009 (H1N1)v-like vaccine (each treatment group) results in an immune response to the vaccine-homologous virus that meets or exceeds the CHMP guidance targets for pandemic vaccine seroconversion rate (SCR), rate of induction of vaccine-homologous reciprocal hemagglutination inhibition (HI) titers greater than or equal to 40 (potential seroprotection rate [SPR]) and geometric mean fold rise (GMFR) 21 days after the first dose of H1N1 vaccine in children 10 to < 18 years of age.
Critère d'inclusion
- Immunization of healthy children aged 10 to less than 18 years against A/California/7/2009 (H1N1)v-like influenza